263 related articles for article (PubMed ID: 30859917)
1. Repurposing strategies for Chagas disease therapy: the effect of imatinib and derivatives against Trypanosoma cruzi.
Simões-Silva MR; De Araújo JS; Peres RB; Da Silva PB; Batista MM; De Azevedo LD; Bastos MM; Bahia MT; Boechat N; Soeiro MNC
Parasitology; 2019 Jul; 146(8):1006-1012. PubMed ID: 30859917
[TBL] [Abstract][Full Text] [Related]
2. Repurposing Strategy of Atorvastatin against Trypanosoma cruzi:
Araujo-Lima CF; Peres RB; Silva PB; Batista MM; Aiub CAF; Felzenszwalb I; Soeiro MNC
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987140
[TBL] [Abstract][Full Text] [Related]
3. Drug repurposing strategy against Trypanosoma cruzi infection: In vitro and in vivo assessment of the activity of metronidazole in mono- and combined therapy.
Simões-Silva MR; De Araújo JS; Oliveira GM; Demarque KC; Peres RB; D'Almeida-Melo I; Batista DGJ; Da Silva CF; Cardoso-Santos C; Da Silva PB; Batista MM; Bahia MT; Soeiro MNC
Biochem Pharmacol; 2017 Dec; 145():46-53. PubMed ID: 28870526
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole.
Torchelsen FKVDS; Silva TM; Milagre MM; Silva RR; Reis LES; Branquinho RT; Silva GN; de Lana M
Parasitol Res; 2021 Apr; 120(4):1511-1517. PubMed ID: 33236174
[TBL] [Abstract][Full Text] [Related]
5. Trypanocidal effect of the benzyl ester of N-propyl oxamate: a bi-potential prodrug for the treatment of experimental Chagas disease.
Wong-Baeza C; Nogueda-Torres B; Serna M; Meza-Toledo S; Baeza I; Wong C
BMC Pharmacol Toxicol; 2015 Apr; 16():10. PubMed ID: 25896924
[TBL] [Abstract][Full Text] [Related]
6. Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease.
García MC; Ponce NE; Sanmarco LM; Manzo RH; Jimenez-Kairuz AF; Aoki MP
Antimicrob Agents Chemother; 2016 Jun; 60(6):3700-8. PubMed ID: 27067322
[TBL] [Abstract][Full Text] [Related]
7. Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi.
Santos EC; Novaes RD; Cupertino MC; Bastos DS; Klein RC; Silva EA; Fietto JL; Talvani A; Bahia MT; Oliveira LL
Antimicrob Agents Chemother; 2015 Oct; 59(10):5999-6006. PubMed ID: 26169419
[TBL] [Abstract][Full Text] [Related]
8. Experimental Combination Therapy with Amiodarone and Low-Dose Benznidazole in a Mouse Model of Trypanosoma cruzi Acute Infection.
Barbosa JMC; Pedra Rezende Y; de Melo TG; de Oliveira G; Cascabulho CM; Pereira ENGDS; Daliry A; Salem KS
Microbiol Spectr; 2022 Feb; 10(1):e0185221. PubMed ID: 35138142
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo drug combination for the treatment of Trypanosoma cruzi infection: A multivariate approach.
Strauss M; Rodrigues JHS; Lo Presti MS; Bazán PC; Báez AL; Paglini-Oliva P; Nakamura CV; Bustamante JM; Rivarola HW
Exp Parasitol; 2018 Jun; 189():19-27. PubMed ID: 29726395
[TBL] [Abstract][Full Text] [Related]
10. Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi
Pandey RP; Nascimento MS; Franco CH; Bortoluci K; Silva MN; Zingales B; Gibaldi D; Castaño Barrios L; Lannes-Vieira J; Cariste LM; Vasconcelos JR; Moraes CB; Freitas-Junior LH; Kalil J; Alcântara L; Cunha-Neto E
Antimicrob Agents Chemother; 2022 Nov; 66(11):e0028422. PubMed ID: 36314800
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of combined therapy with amiodarone and low-dose benznidazole in a mouse model of chronic Trypanosoma cruzi infection.
Barbosa JMC; Pedra-Rezende Y; Mata-Santos HA; Vilar-Pereira G; Melo TG; Ramos IP; Gibaldi D; Moreira OC; Nunes DF; Batista MM; Lannes-Vieira J; Daliry A; Salomão K
Biomed Pharmacother; 2024 Jun; 175():116742. PubMed ID: 38754265
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of essential oil of Syzygium aromaticum alone and in combination with benznidazole on murine oral infection with Trypanosoma cruzi IV.
Zanusso Junior G; Massago M; Kian D; Toledo MJO
Exp Parasitol; 2018 Feb; 185():92-97. PubMed ID: 29305891
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomic analysis of benznidazole-resistant and susceptible Trypanosoma cruzi populations.
Lima DA; Gonçalves LO; Reis-Cunha JL; Guimarães PAS; Ruiz JC; Liarte DB; Murta SMF
Parasit Vectors; 2023 May; 16(1):167. PubMed ID: 37217925
[TBL] [Abstract][Full Text] [Related]
14. Impact of levamisole in co-administration with benznidazole on experimental Chagas disease.
Rocha Simões-Silva M; Brandão Peres R; Britto C; Machado Cascabulho C; de Melo Oliveira G; Nefertiti da Gama A; França da Silva C; Lima da Costa K; Finamore Araújo P; Diego de Souza Campos J; Meuser Batista M; Cristina Demarque K; da Cruz Moreira O; de Nazaré Correia Soeiro M
Parasitology; 2019 Jul; 146(8):1055-1062. PubMed ID: 31046850
[TBL] [Abstract][Full Text] [Related]
15. Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.
Fonseca-Berzal C; Arán VJ; Escario JA; Gómez-Barrio A
Parasitol Res; 2018 Nov; 117(11):3367-3380. PubMed ID: 30232605
[TBL] [Abstract][Full Text] [Related]
16. Benznidazole/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas Disease.
Assíria Fontes Martins T; de Figueiredo Diniz L; Mazzeti AL; da Silva do Nascimento ÁF; Caldas S; Caldas IS; de Andrade IM; Ribeiro I; Bahia MT
PLoS One; 2015; 10(6):e0128707. PubMed ID: 26076455
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo activity of voriconazole and benznidazole combination on trypanosoma cruzi infection models.
Gulin JEN; Eagleson MA; López-Muñoz RA; Solana ME; Altcheh J; García-Bournissen F
Acta Trop; 2020 Nov; 211():105606. PubMed ID: 32598923
[TBL] [Abstract][Full Text] [Related]
18. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
[TBL] [Abstract][Full Text] [Related]
19. New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice.
Bustamante JM; Craft JM; Crowe BD; Ketchie SA; Tarleton RL
J Infect Dis; 2014 Jan; 209(1):150-62. PubMed ID: 23945371
[TBL] [Abstract][Full Text] [Related]
20. In Vitro and In Vivo Trypanosomicidal Action of Novel Arylimidamides against Trypanosoma cruzi.
Guedes-da-Silva FH; Batista DG; Meuser MB; Demarque KC; Fulco TO; Araújo JS; Da Silva PB; Da Silva CF; Patrick DA; Bakunova SM; Bakunov SA; Tidwell RR; Oliveira GM; Britto C; Moreira OC; Soeiro MN
Antimicrob Agents Chemother; 2016 Apr; 60(4):2425-34. PubMed ID: 26856830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
